Literature DB >> 29081873

DYNAMIC PREDICTION FOR MULTIPLE REPEATED MEASURES AND EVENT TIME DATA: AN APPLICATION TO PARKINSON'S DISEASE.

Jue Wang1, Sheng Luo1, Liang Li2.   

Abstract

In many clinical trials studying neurodegenerative diseases such as Parkinson's disease (PD), multiple longitudinal outcomes are collected to fully explore the multidimensional impairment caused by this disease. If the outcomes deteriorate rapidly, patients may reach a level of functional disability sufficient to initiate levodopa therapy for ameliorating disease symptoms. An accurate prediction of the time to functional disability is helpful for clinicians to monitor patients' disease progression and make informative medical decisions. In this article, we first propose a joint model that consists of a semiparametric multilevel latent trait model (MLLTM) for the multiple longitudinal outcomes, and a survival model for event time. The two submodels are linked together by an underlying latent variable. We develop a Bayesian approach for parameter estimation and a dynamic prediction framework for predicting target patients' future outcome trajectories and risk of a survival event, based on their multivariate longitudinal measurements. Our proposed model is evaluated by simulation studies and is applied to the DATATOP study, a motivating clinical trial assessing the effect of deprenyl among patients with early PD.

Entities:  

Keywords:  Area under the ROC curve; clinical trial; failure time; latent trait model

Year:  2017        PMID: 29081873      PMCID: PMC5656296          DOI: 10.1214/17-AOAS1059

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  26 in total

1.  Bayesian approaches to joint cure-rate and longitudinal models with applications to cancer vaccine trials.

Authors:  Elizabeth R Brown; Joseph G Ibrahim
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

2.  Joint models for multivariate longitudinal and multivariate survival data.

Authors:  Yueh-Yun Chi; Joseph G Ibrahim
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

Review 3.  Bayesian methods for latent trait modelling of longitudinal data.

Authors:  David B Dunson
Journal:  Stat Methods Med Res       Date:  2007-07-26       Impact factor: 3.021

4.  Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.

Authors:  Dimitris Rizopoulos
Journal:  Biometrics       Date:  2011-02-09       Impact factor: 2.571

5.  Dynamic predictions with time-dependent covariates in survival analysis using joint modeling and landmarking.

Authors:  Dimitris Rizopoulos; Geert Molenberghs; Emmanuel M E H Lesaffre
Journal:  Biom J       Date:  2017-08-09       Impact factor: 2.207

6.  Analysis of multivariate mixed longitudinal data: a flexible latent process approach.

Authors:  Cécile Proust-Lima; Hélène Amieva; Hélène Jacqmin-Gadda
Journal:  Br J Math Stat Psychol       Date:  2012-10-22       Impact factor: 3.380

Review 7.  Basic concepts and methods for joint models of longitudinal and survival data.

Authors:  Joseph G Ibrahim; Haitao Chu; Liddy M Chen
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

Review 8.  Joint latent class models for longitudinal and time-to-event data: a review.

Authors:  Cécile Proust-Lima; Mbéry Séne; Jeremy M G Taylor; Hélène Jacqmin-Gadda
Journal:  Stat Methods Med Res       Date:  2012-04-19       Impact factor: 3.021

9.  Joint modeling of multivariate longitudinal measurements and survival data with applications to Parkinson's disease.

Authors:  Bo He; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2013-04-16       Impact factor: 3.021

10.  Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective.

Authors:  David J Brooks
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more
  8 in total

1.  A Bayesian approach for individual-level drug benefit-risk assessment.

Authors:  Kan Li; Sheng Luo; Sammy Yuan; Shahrul Mt-Isa
Journal:  Stat Med       Date:  2019-04-15       Impact factor: 2.373

2.  Application of longitudinal item response theory models to modeling Parkinson's disease progression.

Authors:  Haotian Zou; Varun Aggarwal; Glenn T Stebbins; Martijn L T M Müller; Jesse M Cedarbaum; Anne Pedata; Diane Stephenson; Tanya Simuni; Sheng Luo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-09

3.  Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers.

Authors:  Yayuan Zhu; Xuelin Huang; Liang Li
Journal:  Biom J       Date:  2020-03-20       Impact factor: 2.207

4.  Bayesian joint modelling of longitudinal and time to event data: a methodological review.

Authors:  Maha Alsefri; Maria Sudell; Marta García-Fiñana; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2020-04-26       Impact factor: 4.615

5.  Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model.

Authors:  Jue Wang; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2018-10-11       Impact factor: 3.021

6.  Improved Landmark Dynamic Prediction Model to Assess Cardiovascular Disease Risk in On-Treatment Blood Pressure Patients: A Simulation Study and Post Hoc Analysis on SPRINT Data.

Authors:  Mehrab Sayadi; Najaf Zare; Armin Attar; Seyyed Mohammad Taghi Ayatollahi
Journal:  Biomed Res Int       Date:  2020-04-22       Impact factor: 3.411

7.  Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models.

Authors:  Sheng Luo; Haotian Zou; Christopher G Goetz; Dongrak Choi; David Oakes; Tanya Simuni; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2021-08-03

8.  Predicting the Survival of AIDS Patients Using Two Frameworks of Statistical Joint Modeling and Comparing Their Predictive Accuracy.

Authors:  Fatemeh Khorashadizadeh; Hamed Tabesh; Mahboubeh Parsaeian; Habibollah Esmaily; Abbas Rahimi Foroushani
Journal:  Iran J Public Health       Date:  2020-05       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.